search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
BLOOD SCIENCES


Sepsis: plasma viscosity as a diagnostic marker


David Norcliffe, David Manuel and Bernie Benson examine the role of plasma viscosity as a diagnostic marker in sepsis and also plasma–serum viscosity ratio as a predictor of disseminated intravascular coagulation.


Sepsis is a life-threatening condition caused by an abnormal and excessive immune response to infection, which can overwhelm the body and requires immediate medical atention. The infection may be bacterial, viral, fungal or parasitic. Sepsis frequently presents with


symptoms that resemble those of common illnesses, making it susceptible to being undiagnosed. It can develop extremely quickly from initial infection and progression to full septic shock and is regarded as the most common causes of death from infectious diseases or viral infections. Early recognition of sepsis is essential,


as delays in diagnosis and failure to initiate prompt treatment are associated with significantly worse outcomes, including increased morbidity and mortality.1–3


Definition, stages and complications of sepsis In 2016, a new definition of sepsis (Sepsis-3) was developed.4


Sepsis is defined


as life-threatening organ dysfunction caused by a dysregulated host response to infection, replacing the earlier three- stage model, sepsis, severe sepsis, and septic shock. The term ‘severe sepsis’ has been removed. Septic shock is recognised as a subset of sepsis with profound circulatory and metabolic abnormalities. Sepsis is now viewed as a continuum of severity requiring prompt recognition and management. Septic shock is associated with high morbidity and mortality.5–8


Current


guidelines recommend that treatment and resuscitation should be initiated immediately.9 A high proportion of patients with


sepsis develop disseminated intravascular coagulation (DIC) or ‘consumption coagulopathy’ characterised by widespread activation of coagulation pathways leading to depletion of fibrinogen and platelets.10


This results in


a paradoxical state of both microvascular thrombosis and an increased tendency for severe bleeding from multiple sites.


Signs and symptoms of sepsis Sepsis can develop rapidly and can present in diverse ways. The most common symptoms include: fever or hypothermia chills, rigors malaise, fatigue tachycardia (heart rate >90 bpm) tachypnoea (respiratory rate >22/min).


The signs of sepsis.


Systemic and organ-specific features are: Neurological: confusion, altered mental status


June 2026 WWW.PATHOLOGYINPRACTICE.COM 31


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56